目錄:杭州斯達(dá)特生物科技有限公司>>抗體/抗原>>Biosimilar抗體>> S0B0555Anti-PD-L1 Monoclonal Antibody(Atezolizumab)
Atezolizumab, sold under the brand name Tecentriq, is a monoclonal antibody medication used to treat urothelial carcinoma, non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), hepatocellular carcinoma and alveolar soft part sarcoma. It is a fully humanized, engineered monoclonal antibody of IgG1 isotype against the protein programmed cell death-ligand 1 (PD-L1).
(空格分隔,最多3個(gè),單個(gè)標(biāo)簽最多10個(gè)字符)